Bloomberg Talks

U.S. Ambassador to Belgium Bill White, a key figure in U.S.-Belgium relations and a close associate of President Trump, shares insights on pivotal topics. He discusses the promising future of U.S.-Greenland relations amid security concerns. White emphasizes Trump's unwavering support for NATO and how it has spurred increased European defense spending. He also highlights a $30 billion pipeline of U.S.-Belgium trade deals and Belgium's significant F-35 purchase, showcasing the strong transatlantic ties while addressing social and migration reforms.

Sen. Thom Tillis, a U.S. Senator from North Carolina and a key figure on national security and economic issues, discusses pressing topics with Joe Mathieu. He expresses skepticism about the recent peace in Iran, critiques poor White House policy advice, and emphasizes NATO's importance. Tillis also addresses military actions in Greenland and Venezuela, highlighting his commitment to war powers oversight. Additionally, he touches on the controversy surrounding Federal Reserve nominations, stressing the need for clarity before proceeding.

Carolyn Tisch Blodgett, lead owner of Gotham FC and CEO of Next3 Ventures, discusses the dynamic landscape of women's sports. She emphasizes the importance of competitive salaries while highlighting strategies to retain top talent without overspending. Carolyn also shares insights on how investing in coaching and player health contributes to Gotham's success. She addresses the role of U.S. National Team stars in enhancing fan engagement and details the rapid expansion of ownership in women's leagues, signaling a bright future.

Ed Bastian, CEO of Delta Air Lines, offers insights into the airline's thriving premium travel segment, revealing double-digit growth in business travel. He emphasizes international expansion as the key to Delta's future, supported by new Boeing Dreamliner orders. Bastian also discusses potential impacts from proposed credit-card rate caps and highlights the significant role of AmEx partnerships. With a focus on premium demand driving revenue, he shares strategies to address crowded lounges while navigating industry consolidation challenges.

Eric Rosengren, former president of the Federal Reserve Bank of Boston, shares insights on the delicate balance of Fed independence and market reactions. He warns that actions from the administration may undermine confidence in the Fed, complicating potential interest rate cuts. Despite short-term rate projections, he predicts long-term rates could rise due to inflation concerns. His discussion on political pressures influencing Fed appointments highlights the crucial relationship between independence and fiscal policy.

Mike Doustdar, CEO of Novo Nordisk, leads the charge in obesity and diabetes treatments. He shares insights on the launch of an oral version of their popular weight loss drug Wegovy, highlighting its early success and unique formulation. Doustdar delves into the competitive landscape, discussing how their pill offers advantages over others. He also emphasizes the significance of scaling production and innovative pricing strategies. Lastly, he explores the transformative role of AI in accelerating drug discovery and improving patient access.

Nouriel Roubini dives into the transformative power of AI, projecting it will significantly boost US GDP by 2030. He highlights impressive productivity gains since the launch of ChatGPT, raising questions about a 'jobless' growth. Interestingly, he downplays tensions from geopolitical risks, assessing their minimal macro impact. Roubini also tackles AI valuations, the prospects of AGI, and the implications for corporate profits versus real wages, suggesting that firms are reaping most productivity benefits.

Sergio Ermotti, CEO of UBS Group, brings his insight into the shifting landscape of banking and Asian markets. He critiques proposed Swiss banking regulations as excessively strict, emphasizing the need for a competitive environment. Ermotti highlights renewed investor interest in China, discussing rising IPO activities and UBS's plans for growth. He also shares optimism about Japan's market potential and outlines UBS's commitment to talent development in the region. His views on supporting Chinese innovation and navigating new-economy investments are both timely and intriguing.

U.S. Senator Elizabeth Warren, a fierce advocate for financial regulation, discusses pivotal policies on affordability and credit card interest rates. She reveals a surprising call from President Trump after her speech, highlighting her push for bipartisan cooperation on economic issues. Warren emphasizes the need for Democrats to be vocal in their fight for lower costs and critiques economic policies leading to rising expenses. She also touches on the independence of the Federal Reserve and her willingness to pursue testimonies that could impact consumer protection.

Albert Bourla, the Chairman and CEO of Pfizer, shares insights on the company's innovative weight-loss drugs. He emphasizes their aim for superior results and discusses the promising MetSera acquisition, designed for enhanced weight loss with a unique dosing approach. Bourla also expresses satisfaction with Pfizer’s growth trajectory, forecasting impressive sales, while highlighting their commitment to reinvesting in crucial R&D areas like oncology and obesity. His thoughts on engaging with policymakers offer a glimpse into the interplay between business and government in the pharmaceutical sector.